(Q22251013)

7 February 2023

5

Bart C. Jacobs

Bart C.

Jacobs

1 reference

7 February 2023

Bianca van den Berg

1

Bianca

van den Berg

1 reference

7 February 2023

Christa Walgaard

series ordinal

2

author given names

Christa

author last names

Walgaard

1 reference

7 February 2023

Judith Drenthen

series ordinal

3

author given names

Judith

author last names

Drenthen

1 reference

7 February 2023

Christiaan Fokke

series ordinal

4

author given names

Christiaan

author last names

Fokke

1 reference

7 February 2023

language of work or name

English

0 references

publication date

15 July 2014

0 references

published in

Nature Reviews Neurology

0 references

volume

10

0 references

issue

8

0 references

page(s)

469-482

0 references

cites work

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

20 April 2017

Guillain–Barré Syndrome

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

Assessment of current diagnostic criteria for Guillain-Barré syndrome

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

Axonal Guillain-Barré syndrome: concepts and controversies

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

Fisher syndrome: clinical features, immunopathogenesis and management

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

Immunotherapy for Guillain-Barre syndrome: a systematic review

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

Update on Guillain-Barré syndrome

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

Electrodiagnostic criteria for Guillain–Barrè syndrome: A critical revision and the need for an update

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2014.121

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Diagnostic and classification criteria for the Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Epidemiologic features of Guillain-Barré syndrome in São Paulo, Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré syndrome associated with preceding hepatitis E virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Hepatitis E and Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Binational outbreak of Guillain-Barré syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Peripheral neuropathies and anti-glycolipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré syndrome subtypes related to Campylobacter infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Ganglioside complexes as new target antigens in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

The immunobiology of Guillain-Barré syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

The effect of TNF-alpha, FcγR and CD1 polymorphisms on Guillain-Barré syndrome risk: evidences from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Recurrences, vaccinations and long-term symptoms in GBS and CIDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré Syndrome in India: population-based validation of the Brighton criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Pain in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Pain in Guillain-Barre syndrome: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré syndrome: clinical variants and their pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Limb motor nerve dysfunction in Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Conduction block in acute motor axonal neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

The demyelination neurophysiological criteria can be misleading in Campylobacter jejuni-related Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré syndrome during childhood: particular clinical and electrophysiological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Recognizing Guillain-Barre syndrome in preschool children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré syndrome in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Controlled trial prednisolone in acute polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

196th ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8-10 February 2013, Naarden, The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Modifying the Medical Research Council grading system through Rasch analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Intravenously Administered Immunoglobulin in the Treatment of Childhood Guillain-Barre Syndrome: A Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Exchange transfusion: a low-cost alternative for severe childhood Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Treatment guidelines for Guillain-Barré Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

A comparison of immunomodulation therapies in mechanically ventilated patients with Guillain Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Intravenous immunoglobulin therapy for Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Supportive care for patients with Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Selective Digestive Tract Decontamination Decreases Time on Ventilator in Guillain–Barré Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Residual health status after Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Long term disability and social status change after Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Fatigue in immune-mediated neuropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Outcomes of high- and low-intensity rehabilitation programme for persons in chronic phase after Guillain-Barré syndrome: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Residual fatigue in Guillain-Barre syndrome is related to axonal loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Cutaneous innervation in Guillain-Barré syndrome: pathology and clinical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Unmyelinated and myelinated skin nerve damage in Guillain-Barré syndrome: correlation with pain and recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Autonomic involvement in Guillain-Barré syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

The morbidity of Guillain-Barré syndrome admitted to the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Factors predicting extubation success in patients with Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

A clinical prognostic scoring system for Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Campylobacter jejuni infection and Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Early recognition of poor prognosis in Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Motor conduction studies in Guillain-Barré syndrome: description and prognostic value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Indicators of rapid clinical recovery in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré syndrome: incidence and mortality rates in US hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Mortality in Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Influenza vaccine, Guillain–Barré syndrome, and chasing zero

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Pitfalls in electrodiagnosis of Guillain-Barre syndrome subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Early predictors of mechanical ventilation in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Intravenous immunoglobulin for Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Plasma exchange for Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Corticosteroids for Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean island Curaçao

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Fc receptor like 3 in Chinese patients of Han nationality with Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

A Campylobacter jejuni gene associated with immune-mediated neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

31 March 2020

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

7 January 2021

inferred from DOI database lookup

Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Origin of ganglioside complex antibodies in Guillain–Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Recurrent Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Diagnostic considerations in Guillain-Barr� syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Subacute Idiopathic Demyelinating Polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Acute motor conduction block neuropathy Another Guillain-Barre syndrome variant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Pharmacological treatment for pain in Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

This disorder has some nerve: chronic pain in Guillain-Barre syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Guillain-Barré syndrome: subtypes and predictors of outcome from India

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Tracheostomy in Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Long-term prognosis for Guillain-Barré syndrome: evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Fatal Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.121

Small volume plasma exchange in Guillain-Barre syndrome: experience in 25 patients

31 March 2020

1 reference

12 December 2020

Rehabilitation interventions in patients with acute demyelinating inflammatory polyneuropathy: a systematic review

1 reference

12 December 2020

Campylobacter species and Guillain-Barré syndrome

1 reference

12 December 2020

Prediction of respiratory insufficiency in Guillain-Barré syndrome

1 reference

12 December 2020

The prognosis and main prognostic indicators of Guillain-Barré syndrome. A multicentre prospective study of 297 patients. The Italian Guillain-Barré Study Group

1 reference

12 December 2020

High incidence of Guillain-Barre syndrome in children, Bangladesh

1 reference

12 December 2020

Assessment of autonomic dysfunction in childhood guillain-barré syndrome

1 reference

12 December 2020

Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy

1 reference

12 December 2020

Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

12 December 2020

[Imminent respiratory insufficiency in children resulting from Guillain-Barré syndrome]

1 reference

12 December 2020

10.1038/NRNEUROL.2014.121

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1150134

0 references

1150134

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference